BRIEF-Leap Therapeutics says Merck will sponsor and fund initial trials of their combo drug study
June 21, 2017 at 17:41 PM EDT
* Leap Therapeutics - under agreement with unit of Merck, Co to sponsor and fund phase i/ii clinical trials of combination of dkn-01 and keytruda(reg)
